Omnicell, Inc. announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024. Ms. Voynick fills the vacancy resulting from Sara J. White, a Class I director who stepped down from the Company?s Board of Directors, effective January 5, 2024. In addition, the Company announced that Vance Moore will not stand for reelection to the Company?s Board at Omnicell?s 2024 annual meeting of stockholders (the 2024 annual meeting) and effective as of the 2024 annual meeting, the size of the Board will be reduced from ten to nine directors.

Ms. Voynick brings over three decades of experience driving sales and operations at global industry leaders, including in the healthcare technology industry, at the executive and board level. She most recently served as Chief Executive Officer of Sparta Systems Inc., a leading provider of enterprise-quality management software solutions. Prior to Sparta Systems, Ms. Voynick served as Chief Operating Officer at Allscripts Healthcare Solutions, Inc. (n/k/a Veradigm Inc.), as Executive Vice President of global sales, services, and support at Misys Healthcare Systems, and in various management positions at Oracle, SAP, Siebel Systems, Gartner, Ariba, and Accenture.

Ms. Voynick is currently board chair of AGS Health LLC, and has held board positions for several other organizations, including Skydeck Acquisition Corp., CDK Global, Inc., r3, Advanced MD Health, Jefferson Health, Philadelphia University and Thomas Jefferson University. Ms. Voynick has been appointed to the Board?s Corporate Governance Committee. Following the 2024 annual meeting, the Omnicell Board will be comprised of nine directors, eight of whom are independent, and all of whom bring a broad range of expertise and skills necessary to oversee and direct the Company?s business.

Six of those independent directors have been added to the Board in the last four years.